Chronotherapies for Parkinson's disease.


Journal

Progress in neurobiology
ISSN: 1873-5118
Titre abrégé: Prog Neurobiol
Pays: England
ID NLM: 0370121

Informations de publication

Date de publication:
03 2019
Historique:
received: 25 06 2018
revised: 18 11 2018
accepted: 14 01 2019
pubmed: 19 1 2019
medline: 10 3 2020
entrez: 19 1 2019
Statut: ppublish

Résumé

Parkinson's disease (PD) is the second-most common progressive neurodegenerative disorder. Although the clinical diagnosis of PD is still based on its cardinal motor dysfunctions, several non-motor symptoms (NMS) have been established as integral part of the disease. Unlike motor disorders, development of therapies against NMS are still challenging and remain a critical unmet clinical need. During the last decade, several studies have characterised the molecular, physiological and behavioural alterations of the circadian system in PD patients. As a consequence, and given the ubiquitous nature of circadian rhythms in the entire organism, the biological clock has emerged as a potential therapeutic target to ease suffering from both motor and NMS in PD patients. Here we discuss the emerging field of using bright light, physical exercise and melatonin as chronotherapeutic tools to alleviate motor disorders, sleep/wake alterations, anxiety and depression in PD patients. We also highlight the potential of these readily available therapies to improve the general quality of life and wellbeing of PD patients. Finally, we provide specific data- and mechanisms-driven recommendations that might help improve the therapeutic benefit of light and physical exercise in PD patients.

Identifiants

pubmed: 30658126
pii: S0301-0082(18)30099-6
doi: 10.1016/j.pneurobio.2019.01.002
pmc: PMC6377295
mid: NIHMS1519137
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-27

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS099055
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Chronobiol Int. 2006;23(1-2):403-12
pubmed: 16687313
Trends Neurosci. 2018 May;41(5):252-254
pubmed: 29588060
N Engl J Med. 2003 Nov 13;349(20):1925-34
pubmed: 14614167
Sleep. 2004 Dec 15;27(8):1542-51
pubmed: 15683146
BMC Nephrol. 2012 Aug 30;13:96
pubmed: 22935542
Neurobiol Sleep Circadian Rhythms. 2017 Jan;2:53-58
pubmed: 28713867
J Neurol. 2007 Apr;254(4):459-64
pubmed: 17404779
Nat Rev Genet. 2008 Oct;9(10):764-75
pubmed: 18802415
Arch Gen Psychiatry. 2001 Jan;58(1):69-75
pubmed: 11146760
J Pineal Res. 2003 Oct;35(3):149-57
pubmed: 12932197
Nature. 1989 May 4;339(6219):49-51
pubmed: 2654641
Physiol Behav. 2017 Aug 1;177:221-229
pubmed: 28472667
J Neurol. 2015 Nov;262(11):2564-71
pubmed: 26338815
Lancet Neurol. 2012 May;11(5):429-42
pubmed: 22516078
Prog Brain Res. 2012;199:305-336
pubmed: 22877673
Front Neurol. 2013 May 15;4:49
pubmed: 23720648
Nat Neurosci. 2018 Oct;21(10):1370-1379
pubmed: 30250265
Nat Neurosci. 2003 Oct;6(10):1086-90
pubmed: 12958601
Sci Transl Med. 2011 Apr 20;3(79):79ps14
pubmed: 21508309
J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):176-185
pubmed: 27799297
JAMA Neurol. 2013 Dec;70(12):1544-51
pubmed: 24145819
Nature. 1977 Sep 22;269(5626):340-2
pubmed: 904687
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S101-4
pubmed: 20082966
Science. 2016 Nov 25;354(6315):994-999
pubmed: 27885004
JAMA. 2008 Jun 11;299(22):2642-55
pubmed: 18544724
Auton Neurosci. 2011 Dec 7;165(2):195-200
pubmed: 21871844
Nat Rev Neurosci. 2014 Jul;15(7):443-54
pubmed: 24917305
Acta Neuropathol Commun. 2018 Sep 10;6(1):90
pubmed: 30201049
Neurobiol Sleep Circadian Rhythms. 2017 Jan 20;2:39-52
pubmed: 31236494
Exp Neurol. 2013 May;243:45-56
pubmed: 22935723
Nat Rev Neurosci. 2011 Sep 02;12(10):553-69
pubmed: 21886186
Nature. 2008 May 1;453(7191):102-5
pubmed: 18432195
CNS Spectr. 2005 Aug;10(8):647-63; quiz 672
pubmed: 16041296
Neurobiol Aging. 1997 May-Jun;18(3):285-9
pubmed: 9263193
Geriatr Gerontol Int. 2012 Jul;12(3):491-8
pubmed: 22233227
Neuroscience. 2007 Jul 13;147(3):811-23
pubmed: 17574765
JAMA Neurol. 2014 Nov;71(11):1455-6
pubmed: 25383775
Sleep Med Rev. 2017 Oct;35:33-50
pubmed: 27863901
Eur J Intern Med. 2006 Oct;17(6):417-20
pubmed: 16962949
Sleep Med. 2010 Oct;11(9):934-40
pubmed: 20813580
Eur J Appl Physiol. 2007 Mar;99(4):331-41
pubmed: 17165050
Sci Rep. 2018 May 17;8(1):7796
pubmed: 29773814
Front Neurol. 2017 May 04;8:162
pubmed: 28522986
Nat Rev Genet. 2005 Jul;6(7):544-56
pubmed: 15951747
Front Neurol. 2018 Mar 26;9:157
pubmed: 29632508
Annu Rev Genomics Hum Genet. 2004;5:407-41
pubmed: 15485355
Nat Rev Neurosci. 2017 Jul;18(7):435-450
pubmed: 28592904
J Neurosci. 2010 Nov 3;30(44):14691-4
pubmed: 21048126
Curr Biol. 2016 Jul 25;26(14):1843-53
pubmed: 27426518
Nature. 1987 Nov 26-Dec 2;330(6146):372-3
pubmed: 3683553
Nat Rev Neurosci. 2008 Dec;9(12):910-9
pubmed: 18985047
Front Neurosci. 2016 Jan 11;9:500
pubmed: 26793049
Mov Disord. 2007 Jul 30;22(10):1495-1498
pubmed: 17516492
Sleep Med Rev. 2016 Oct;29:52-62
pubmed: 26606319
Front Neurosci. 2017 Nov 23;11:658
pubmed: 29217998
J Neurosci. 2000 Dec 15;20(24):9326-32
pubmed: 11125012
Sleep. 2006 Apr;29(4):455-61
pubmed: 16676778
Mov Disord. 2011 Mar;26(4):760-1
pubmed: 21271615
Nat Rev Dis Primers. 2017 Mar 23;3:17013
pubmed: 28332488
Neurosci Lett. 2011 Jul 25;499(3):186-8
pubmed: 21658431
Lancet Neurol. 2009 May;8(5):464-74
pubmed: 19375664
Neurology. 1990 Mar;40(3 Pt 1):467-70
pubmed: 2314590
J Neuroendocrinol. 2011 Jun;23(6):519-24
pubmed: 21466597
Lancet Neurol. 2009 Dec;8(12):1158-71
pubmed: 19909914
Jpn J Psychiatry Neurol. 1994 Sep;48(3):583-7
pubmed: 7891422
Nat Neurosci. 2003 Sep;6(9):974-80
pubmed: 12925855
Trends Endocrinol Metab. 2016 Apr;27(4):192-203
pubmed: 26947521
Science. 2009 Apr 24;324(5926):516-9
pubmed: 19390047
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):107-10
pubmed: 20875835
Sleep Med. 2005 Sep;6(5):459-66
pubmed: 16084125
Prog Brain Res. 2012;199:203-218
pubmed: 22877667
Nat Med. 2010 Jun;16(6):653-61
pubmed: 20495568
Brain. 2008 Oct;131(Pt 10):2720-8
pubmed: 18941146
Trends Pharmacol Sci. 2013 Nov;34(11):605-19
pubmed: 24120229
Neurobiol Sleep Circadian Rhythms. 2016 Nov 30;2:27-38
pubmed: 31236493
Am J Physiol. 1998 Apr;274(4 Pt 2):R991-6
pubmed: 9575961
BMC Psychiatry. 2016 Oct 21;16(1):355
pubmed: 27769202
J Biol Rhythms. 2003 Apr;18(2):170-8
pubmed: 12693871
Neurotox Res. 2013 Apr;23(3):267-300
pubmed: 22739839
Mov Disord. 2017 May;32(5):682-692
pubmed: 27859638
Neurosci Lett. 2005 Aug 26;384(3):316-20
pubmed: 15919151
Science. 2016 Nov 25;354(6315):1004-1008
pubmed: 27885006
Brain Res. 2009 Jul 7;1279:90-8
pubmed: 19450569
Clin Neuropharmacol. 2003 Mar-Apr;26(2):65-72
pubmed: 12671525
J Neurosci. 2009 May 13;29(19):6336-47
pubmed: 19439610
Brain Struct Funct. 2018 Jul;223(6):2641-2652
pubmed: 29560509
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4898-903
pubmed: 18347342
Nat Rev Neurol. 2011 Jul 12;7(9):528-34
pubmed: 21750523
Brain. 2009 May;132(Pt 5):1128-45
pubmed: 19336464
Aging Dis. 2012 Apr;3(2):194-225
pubmed: 22724080
Sleep Med. 2014 Mar;15(3):342-7
pubmed: 24529544
Science. 2005 Mar 4;307(5714):1476-9
pubmed: 15746431
Neurosci Bull. 2017 Feb;33(1):62-72
pubmed: 27995565
Lancet Neurol. 2006 Mar;5(3):235-45
pubmed: 16488379
Nat Rev Neurosci. 2008 Jan;9(1):58-65
pubmed: 18094706
Curr Biol. 2016 May 23;26(10):R432-43
pubmed: 27218855
Biochem Pharmacol. 2008 Jun 1;75(11):2070-9
pubmed: 18384754
Chronobiol Int. 2007;24(3):521-37
pubmed: 17612949
Rev Neurosci. 2012 Mar 01;23(2):199-226
pubmed: 22499678
Mov Disord. 2009;24 Suppl 2:S665-70
pubmed: 19877244
Mov Disord. 2018 Aug;33(8):1315-1324
pubmed: 29737566
Sleep Med Rev. 2007 Dec;11(6):497-507
pubmed: 17964200
JAMA Neurol. 2014 Apr;71(4):499-504
pubmed: 24514863
Nat Rev Neurol. 2014 Dec;10(12):683-93
pubmed: 25385339
Sleep Med Rev. 2016 Feb;25:95-111
pubmed: 26163055
JAMA Neurol. 2014 May;71(5):589-595
pubmed: 24687146
Br J Pharmacol. 2011 Oct;164(4):1357-91
pubmed: 21486284
Mov Disord. 2016 Mar;31(3):260-9
pubmed: 26826022
Sleep Med. 2018 Apr;44:24-31
pubmed: 29530365
Neuron. 2014 Nov 5;84(3):594-607
pubmed: 25442938
Annu Rev Physiol. 2010;72:517-49
pubmed: 20148687
Parkinsonism Relat Disord. 2013 Jul;19(7):670-5
pubmed: 23561946
JAMA Neurol. 2017 Apr 01;74(4):411-418
pubmed: 28241159
Physiotherapy. 2014 Jun;100(2):134-41
pubmed: 23972329
Eur J Neurol. 2010 Apr;17(4):550-4
pubmed: 19912323
Trends Pharmacol Sci. 2018 Sep;39(9):812-827
pubmed: 30060890
J Biol Rhythms. 1997 Apr;12(2):146-56
pubmed: 9090568
Neurosci Lett. 2014 Jun 13;571:34-8
pubmed: 24785101
Brain Res Brain Res Rev. 2005 Nov;49(3):429-54
pubmed: 16269313
Am J Ophthalmol. 1995 Feb;119(2):202-10
pubmed: 7832227
Neurosci Biobehav Rev. 2007;31(5):775-824
pubmed: 17445891
J Neurosci. 2007 Jul 18;27(29):7869-78
pubmed: 17634381
JAMA Neurol. 2014 Apr;71(4):463-9
pubmed: 24566763
Nat Rev Drug Discov. 2011 May;10(5):377-93
pubmed: 21532567

Auteurs

Karim Fifel (K)

International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan; Department of Molecular Cell Biology, Neurophysiology unit, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, the Netherlands; Stem Cell and Brain Research Institute, Department of Chronobiology, 18 Avenue du Doyen Lépine, 69500, Bron, France; Laboratory of Pharmacology, Neurobiology and Behavior, Associated CNRST Unit (URAC-37), Cadi Ayyad University, Marrakech, Morocco. Electronic address: fifel-k@hotmail.com.

Aleksandar Videnovic (A)

Movement Disorders Unit and Division of Sleep Medicine, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 600, Boston, MA, 02446, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH